“One Month to Save Lives”: Families race against 1st August deadline to secure access to life-saving rare disease drug

Contributed by: PA Media Assignments

Logo

Images

PA Media Assignments associated0

PA Media Assignments associated1

PA Media Assignments associated2

Tags

NPUK

Xenpozyme

More Like This

Sanofi responds to NICE negative FAD of olipudase alfa

Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases

PR Newswire associated0

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively

Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025

New documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease

AQNEURSA® (levacetylleucine) Recommended for EU Approval by the CHMP to Treat Niemann-Pick Disease Type C

PR Newswire associated0

Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies